Purchase this report

Non-melanoma Skin Cancer Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Published	Pages	Publisher	Report code
Jan 2024	123	Prodture	ASDR-613718

Published: Jan 2024 - Pages : 123 - Publisher : Prodture - Report code : ASDR-613718

Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Prote... Published: April, 2021 - Pages: 35
Cells Expressing Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - ... Published: April, 2021 - Pages: 35
Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Developm... Published: April, 2021 - Pages: 35
Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X... Published: April, 2021 - Pages: 45
Skin Cancer Diagnostics & Therapeutics Market by Disease Type (Melanoma, Non-melanoma), Type (Diagnosis, Therapeutics) -... Published: October, 2023 - Pages: 184
Non-melanoma Skin Cancer Market - Global Market Report (2024 to 2034) Published: January, 2024 - Pages: 170
Nanotechnology in Cancer Treatment: Technologies and Global Markets Published: April, 2025 - Pages: 107
Cancer Immunotherapy: Technologies and Global Markets Published: April, 2025 - Pages: 203
Oncolytic Virus Therapies Market by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), ... Published: June, 2023 - Pages: 143
Non-Melanoma Skin Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-20... Published: November, 2023 - Pages: 147